Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Provenge receives fast track designation

Sep. 8, 2003

Partial clinical hold on phase III Oncophage trials

Sep. 5, 2003

New phase I/II trial to evaluate Xcellerated T Cells in treatment of CLL

Sep. 2, 2003

Health Canada accepts Bexxar under priority review

Aug. 28, 2003

Development of AS-1403 discontinued following phase I biodistribution results

Aug. 27, 2003

German permits for 1D09C3 pave way for E.U. clinical trials

Aug. 26, 2003

Intravesical rhIL-12 in recurrent STCC of the bladder

Aug. 20, 2003

SGN-35 selectively targets CD30-positive malignancies in models of Hodgkin's disease

Aug. 13, 2003

Scancell and Celltech collaborate on antibody therapeutics to Lewis(y/b)

Aug. 11, 2003

GPC Biotech makes progress on various fronts with 1D09C3

Aug. 6, 2003

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...